期刊文献+

严重的糖尿病血管病变的发生机制及其动物模型制作进展 被引量:5

Mechanism and research progress of severe diabetic vasculopathy and related experimental animal studies
下载PDF
导出
摘要 2型糖尿病(DM)并发的动脉粥样硬化(AS)由于具有斑块不稳定、供血区缺血严重及治疗后再狭窄率高等特点成为导致2型DM患者死亡及截肢最常见病因。对2型DM血管并发症制定并实施针对性强的治疗方案对降低此类疾病对人类健康的危害有重要意义。而2型DM背景下严重的血管病变动物模型的建立,则为研究并进一步实施2型DM血管并发症治疗方案提供了实验基础。本文首先对2型DM并发的严重的血管病变发生机制进行探讨,进一步对现阶段国内外建立此类血管病变动物模型的实验方法进行综述。 Diabetes mellitus( DM) complicated with atherosclerosis( AS) is the most common cause of amputation and death in patients with type 2 DM due to the instability of plaque,severe ischemia and the high rate of restenosis after treatment. It is important to reduce the diabetic vascular complications in those patients. Establishment of animal models of severe diabetic vasculopathy will provide an experimental basis for further studies on those complications. In this paper,we will firstly discuss the mechanism of the development of severe diabetic vasculopathy and then review the methods referring to the establishment of this kind of animal models worldwide.
出处 《中国实验动物学报》 CAS CSCD 北大核心 2016年第3期327-331,共5页 Acta Laboratorium Animalis Scientia Sinica
关键词 糖尿病 血管病变 动物模型 Diabetes mellitus Vasculopathy Animal model
  • 相关文献

参考文献39

  • 1Tang YZ, Wang G, Jiang ZH, et al. Efficacy and safety of vilda- gliptin, sitagliptin, and linagliptin as add-on therapy in Chinese patients with T21)M inadequately controlled with dual combina- tion of insulin and traditional oral hypoglycemic agent [ J]. Dia- betol Metab Syndr, 2015, 7: 91.
  • 2Rhee SY, Kim YS. Peripheral arterial disease in patients with type 2 diabetes mellitus [ J]. Diabet metab J, 2015, 39 (4) : 283 - 290.
  • 3Kohen Avramoglu R, Laplante MA, Le Quang K, et al. Cardio- vascular complications (CVC) are the most common causes of death in patients with type 2 diabetes (T2D) [J]. Can J Diabe- tes, 2013, (5): 351 -358.
  • 4(UKPDS) GROUP. UPDS. Intensive blood glucose control with sulphonyl ureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes [ J ]. Laneet, 1998, 352:837 -853.
  • 5Ritsinger V, Saleh N, Lagerqvist B, et al. High event rate after a first percutaneous coronary intervention in patients with diabetes mellitus: results from the Swedish coronary angiography and an- gioplasty registry [ J]. Circ Cardiovasc Interv, 2015, $ (6) : e002328.
  • 6Karin E. Bornfeldt. 2013 Russell Ross Memorial Lecture in Vas- cular Biology : Cellular and molecular mechanisms of diabetes-ac- celerated atherosclerosis [ J ]. Arterioscler Thromb Vasc Biol, 2014 , 34(4): 705 -714.
  • 7Nishizawa T, Bornfeldt KE. Diabetic vascular disease and the potential role of macrophage glucose metabolism[J].. Ann Med, 2012, 44(6) 555-563.
  • 8Nishizawa T, Bornfeldt KE. Diabetic vascular disease and the potential role of macrophage glucose metabolism [ J]. Ann Med, 2012, 44(6): 555 -563.
  • 9Sun H, Zhang X, Zhao L, et al. Attenuation of atherosclerotic lesions in diabetic apofipoprotein E-deficient mice using gene si- lencing of macrophage migration inhibitory factor [ J]. J Cell Mol Med, 2015, 19(4) : 836 -849,.
  • 10李丹,李玉洁,杨庆,陈颖,翁小刚,邹丽娟,朱晓新.血管内皮功能障碍与动脉粥样硬化研究进展[J].中国实验方剂学杂志,2012,18(8):272-276. 被引量:110

二级参考文献224

共引文献238

同被引文献55

引证文献5

二级引证文献44

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部